NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/29/2025
Back to search
Official data from USPTO
BEACON THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
21
Latest update
04/30/2025
Trademark type
Combined
Nice classes
42
Filing date
10/30/2023
Registration date
04/29/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/29/2025
Last transaction
04/30/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
5
Owner type
24
Owner location
London
Examiner
WATKINS, JONATHAN
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the stylized blue text 'BEACON" above the stylized blue text "THERAPEUTICS". The letter "O" in the word "BEACON" is replaced by a circle design made up of six inward-pointing blue triangles.
Holders and representatives
Holders
Beacon Therapeutics Limited
Representatives
Robert B.G. Horowitz, Esq. BAKER & HOSTETLER LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Research and development services in the fields of pharmaceutical preparations and substances for the treatment of disorders relating to the eyebiotechnological preparations for the treatment of disorders relating to the eyepreparations for gene therapy and cell therapy for the treatment of disorders relating to the eye and genetic medicines for the treatment of disorders relating to the eye; consulting services for others in the field of design planning and implementation project management of clinical trials in the fields of pharmaceutical preparations and substances for the treatment of disorders relating to the eyebiotechnological preparations for the treatment of disorders relating to the eyepreparations for gene therapy and cell therapy for the treatment of disorders relating to the eye and genetic medicines for the treatment of disorders relating to the eye; scientific research in the nature of conducting clinical trials for others in the fields of pharmaceutical preparations and substances for the treatment of disorders relating to the eyebiotechnological preparations for the treatment of disorders relating to the eyepreparations for gene therapy and cell therapy for the treatment of disorders relating to the eye and genetic medicines for the treatment of disorders relating to the eye
Publications
History of USPTO decisions and trademark events.
21 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
04/29/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/11/2025
PUBO
PUBLISHED FOR OPPOSITION
03/11/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/05/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/19/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/22/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/22/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/22/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/22/2024
GNRT
NON-FINAL ACTION E-MAILED
10/22/2024
CNRT
NON-FINAL ACTION WRITTEN
10/22/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/16/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/16/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/16/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/15/2024
GNRT
NON-FINAL ACTION E-MAILED
06/15/2024
CNRT
NON-FINAL ACTION WRITTEN
06/15/2024
DOCK
ASSIGNED TO EXAMINER
06/11/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/08/2023
NWAP
NEW APPLICATION ENTERED
11/02/2023
Continuous trademark protection
Get notified about every new filing that threatens BEACON THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.